Trials / Terminated
TerminatedNCT01134445
An Electronic Data Capture Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip Replacement
Prospective, International Multi-centre, Uncontrolled, Post Marketing Surveillance Study to Monitor the Long-term Performance of the DePuy PROXIMA™ Hip in Subjects With Indications Suitable for a Primary Total Hip Arthroplasty
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- DePuy International · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to monitor the performance of the DePuy PROXIMA™ hip in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments.
Conditions
- Rheumatoid Arthritis
- Osteoarthritis
- Post-traumatic Arthritis
- Avascular Necrosis
- Traumatic Femoral Fractures
- Congenital Hip Dysplasia
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DePuy Proxima™ Hip | A short, anatomic, cementless femoral component for use in total hip arthroplasty |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2016-01-01
- Completion
- 2016-06-01
- First posted
- 2010-06-02
- Last updated
- 2017-06-26
Locations
4 sites across 4 countries: France, Portugal, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT01134445. Inclusion in this directory is not an endorsement.